Uber, DraftKings, Seagen, Activision Blizzard and many more

Uber CEO Dara Khasroshahi speaking at a product launch event in San Francisco, California on September 2, 201.

Philip Pacheco | AFP via Getty Images

Check out the companies that make headlines in afternoon trading.

Uber-Ride-Healing Giant increased its stock by 11% while the company raised its third-quarter financial outlook on its regulatory filings. Uber bookings and consolidated earnings are now expected to be better than the first report. CEO Dara Khasroshahi also told CNBC that he sees the price of the ride rising towards the end of the year.

Draftkings – Shares of online gaming giant UK sports betting company have plunged more than 3% after receiving news of a bid to acquire Entain. The offer is valued at ২০ 20 billion and is based mainly on Draftkings stock with cash, sources told CNBC.

SIGEN – The share of drug manufacturers has risen more than 5% since the Food and Administration Administration announced the immediate approval of its drug TIVDAK, which treats adult patients with recurrent or metastatic cervical cancer.

Activation Blizzard – The video gaming company’s shares sank 2.9% after the Wall Street Journal, citing people familiar with the matter, said the Securities and Exchange Commission is investigating Activism Blizzard’s allegations of sexual misconduct and discrimination against employees.

ConocoPhillips – Shares of ConocoPhillips and Shell ConocoPhillips rose 3% the day after the announcement of the sale of ট 9.5 billion in West Texas oil field assets. The deal gives ConocoPhillips an additional 225,000 acres of energy resources. London-traded shares of Royal Dutch Shell have also moved higher.

Autozone – Shares of Autozone rose 4.2% after auto parts retailers reported strong quarterly earnings. Earnings per share of $ 35.72 beat analysts ’estimates of $ 29.88.

Big Lots – Retail stock fell more than 5% on Tuesday after Piper Sandler neutralized Big Lots from excess weight. The investment firm said in a note to clients that the cessation of financial stimulus and rising costs would hurt the retailer next year.

Shares of Johnson & Johnson-Drug Manufacturer rose nearly 1% to 94% effective after announcing its Covid-19 booster shot when administered two months after the first dose in the U.S., the company said, boosting booster antibody levels four to six times a chance.

– With reports from CNBC’s Eun Lee, Jesse Pound, Tanaya Machil and Hannah Miao.

Become a smart investor with CNBC Pro.
Get access to stock picks, analyst calls, exclusive interviews and CNBC TV.
Sign up to get started a Free trial today

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button